Idiopathic lobular panniculitis in rheumatology practice: The authors’ own data
Егорова О. Н., Белов Б. С., Глухова С. И., Раденска-Лоповок С. Г.
Научно-практическая ревматология
Т. 56, Вып. 3, С. 339-345
Опубликовано: 2018
Тип ресурса: Статья
DOI:10.14412/1995-4484-2018-339-345
Аннотация:
Idiopathic lobular panniculitis (ILP) (synonym: Weber-Christian panniculitis) is the least studied disease in the group of systemic connective tissue lesions and characterized by systemic damage to subcutaneous adipose tissue (SAT). There is no unified concept of the etiology and pathogenesis of ILP now. The literature contains almost no data on the diagnostic value of laboratory studies and therapeutic approaches, which served as the basis for this investigation. Objective: to investigate the relationship between the clinical presentation of ILP and immune inflammatory parameters in patients with this disease. Subjects and methods. Examinations were made in 67 patients (9 men and 58 women) aged 20 to 76 years with a verified diagnosis of ILP (median duration, 78.91 [48; 540] months), who were followed up at the V.A. Nasonova Research Institute of Rheumatology for the period 2007 to 2017. The determination of α1-antitrypsin titer, liver fractions, amylase, lipase, trypsin, ferritin, cr
Ключевые слова:
Clinical manifestations; Diagnosis; Idiopathic lobular panniculitis; Treatment
Язык текста: Русский
ISSN: 1995-4492
Егорова О. Н.
Белов Б. С.
Глухова С. И.
Раденска-Лоповок С. Г. Стефка Господинова 1951-
Egorova O. N.
Belov B. S.
Glukhova S. I.
Radenska-Lopovok S. G. Stefka Gospodinova 1951-
Idiopathic lobular panniculitis in rheumatology practice: The authors’ own data
Текст визуальный непосредственный
Научно-практическая ревматология
ИМА-Пресс
Т. 56, Вып. 3 С. 339-345
2018
Статья
Clinical manifestations Diagnosis Idiopathic lobular panniculitis Treatment
Idiopathic lobular panniculitis (ILP) (synonym: Weber-Christian panniculitis) is the least studied disease in the group of systemic connective tissue lesions and characterized by systemic damage to subcutaneous adipose tissue (SAT). There is no unified concept of the etiology and pathogenesis of ILP now. The literature contains almost no data on the diagnostic value of laboratory studies and therapeutic approaches, which served as the basis for this investigation. Objective: to investigate the relationship between the clinical presentation of ILP and immune inflammatory parameters in patients with this disease. Subjects and methods. Examinations were made in 67 patients (9 men and 58 women) aged 20 to 76 years with a verified diagnosis of ILP (median duration, 78.91 [48; 540] months), who were followed up at the V.A. Nasonova Research Institute of Rheumatology for the period 2007 to 2017. The determination of α1-antitrypsin titer, liver fractions, amylase, lipase, trypsin, ferritin, cr